Treatment Overview
Electrical cardioversion is a procedure in
which an electric current is used to reset the heart's rhythm back to its
regular pattern (normal sinus rhythm). The low-voltage
electric current enters the body through metal paddles or patches applied to
the chest wall. Cardioversion is used:
Before cardioversion for atrial fibrillation, you will be
given medication to control pain and cause relaxation.
See
illustrations of:
What To Expect After Treatment
If you have had atrial fibrillation
for longer than 48 hours, your doctor will probably recommend that you take the
anticoagulant
warfarin(such as Coumadin) for at least 3 weeks
before and for 1 to 3 months after the procedure.
If you have had
atrial fibrillation for less than 48 hours, anticoagulants may not be needed
before this procedure. However, you may still need to take anticoagulants for
at least 4 weeks after this procedure.
Alternately, if you have
had atrial fibrillation for more than 48 hours but a test called
transesophageal echocardiogram has ruled out the
presence of blood clots in the upper heart chambers (atria), you will not need
anticoagulants before the procedure. However, you will still need to take
anticoagulants for at least 1 month after cardioversion, even if no clots are
seen.
Additional medications to help prevent the return of heart
rhythm problems (antiarrhythmics) also may be given before and after the
procedure. Your risk of developing atrial fibrillation again is greater if
antiarrhythmics are not used following cardioversion.
After
cardioversion, you will be monitored to ensure that you have a stable heart
rhythm.
Why It Is Done
Cardioversion is used as an
emergency procedure when symptoms of very low blood pressure, chest pain, or
heart failure caused by rapid, irregular atrial fibrillation are
present.
Cardioversion also is used in nonemergency situations to
correct atrial fibrillation when medications have not been effective. Some
doctors consider it the first choice in younger people or people who have
developed atrial fibrillation within the last 48 hours.
How Well It Works
The success of electrical
cardioversion depends on how long you have had atrial fibrillation and what is
causing it. Cardioversion is less successful if you have had atrial
fibrillation for longer than 1 year.
Electrical cardioversion is
an effective treatment for recent-onset atrial fibrillation. About 86% of
people who receive cardioversion return to
normal sinus rhythm immediately after the procedure.
This success rate increases to 94% when antiarrhythmic medications are given
before cardioversion. However, only about 23% of those will remain in normal
sinus rhythm after 1 year, and additional treatment may be needed.1 Although cardioversion can return the heart rhythm to normal,
it does not act in the long term to maintain a normal rhythm.
Risks
Risks of the procedure include the
following:
- A blood clot may become dislodged from the
heart and cause a stroke. Your doctor will try to decrease this risk by using
anticoagulants or other measures.
- The procedure may not work.
Additional cardioversion or other treatment may be
needed.
- Antiarrhythmic medications used before and after
cardioversion or even the cardioversion itself may cause a life-threatening
irregular heartbeat.
- You can have a reaction to the sedative given before the
procedure. Harmful reactions are rare.
- You can get a small area of
burn on your skin where the paddles are placed.
What To Think About
Cardioversion may be less
successful or may not be recommended if you:
- Have had atrial fibrillation for more than a
year.
- Have significant valve problems.
- Have an enlarged
heart as a result of
heart failure or
cardiomyopathy.
- Have multiple recurrences
of atrial fibrillation.
Cardioversion is more likely to be successful if:
- Atrial fibrillation has been present for less
than a year.
- This is your first episode of atrial
fibrillation.
- You are young.
- Antiarrhythmic medications
are used along with cardioversion.
Complete the special treatment information form (PDF)
(What is a PDF document?)
to help you understand this treatment.
References
Citations
Fuster V, et al. (2006). ACC/AHA/ESC 2006 guidelines
for the management of patients with atrial fibrillation-Executive Summary. A
report of the American College of Cardiology/American Heart Association Task
Force on Practice Guidelines and the European Society of Cardiology Committee
for Practice Guidelines (Writing committee to revise the 2001 guidelines for
the management of patients with atrial fibrillation). Circulation, 114(7): 700-752.
Credits
| Author | Robin Parks, MS |
| Editor | Kathleen M. Ariss, MS |
| Associate Editor | Pat Truman, MATC |
| Primary Medical Reviewer | Caroline S. Rhoads, MD - Internal Medicine |
| Specialist Medical Reviewer | John M. Miller, MD - Electrophysiology |
| Last Updated | December 18, 2008 |